[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to YF-VAX in Adults

What is the purpose of the study?

This study is looking to describe the safety and tolerability of a novel Yellow Fever vaccine. Yellow Fever is a mosquito-borne disease that is caused by a virus that causes a wide range of health problems, from mild symptoms to severe illness. Yellow Fever is widespread in sub-Saharan Africa and tropical South America and continues to be a significant health problem to many residents and non-vaccinated travelers of these regions. This vaccine is expected to help prevent Yellow Fever as there is no specific treatment for it.

Upstate Institutional Review Board (IRB) Number:

1737734

Study/Protocol ID:

VYF02

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Kristopher M Paolino

What is involved if I participate?

  • How long is the study?
    10 visits over 5 years
  • Is transportation provided or reimbursed?
    Yes
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Collection of medical history, physical exam, blood draw. May receive trial vaccine or currently approved YF-VAX.

Where will the study take place?

Upstate Community Campus

Other Information:

Contact Keely Terrillion
315-464-9869
Trials@upstate.edu

Who can I contact for more information?

Name: Kianna Ripich
Phone: 315-464-6488
Email: ripichk@upstate.edu

Return to Previous Page || Search Again

Top